β coefficient | OR (95% CI) | P value | |
---|---|---|---|
Mortality at day 14 | |||
Healthcare-associated bacteremia | 0.06 | 1.06 (0.52–2.14) | 0.86 |
Charlson index | 0.32 | 1.37 (1.16–1.63) | <0.001 |
Presentation with severe sepsis or shock | 1.74 | 5.70 (2.13–15.23) | 0.001 |
Urinary tract source | -1.85 | 0.15 (0.05–0.44) | <0.001 |
Inappropriate empirical therapy | 1.18 | 3.33 (1.42-7.69) | 0.005 |
Mortality at day 30 | |||
Healthcare-associated bacteremia | -1.75 | 0.83 (0.45–1.57) | 0.57 |
Age | 0.02 | 1.02 (1.00–1.04) | 0.01 |
Charlson index | 0.34 | 1.41 (1.22–1.63) | <0.001 |
Pitt score ≥ 2 | 0.16 | 1.18- (0.99–1.41) | 0.06 |
Presentation with severe sepsis or shock | 1.20 | 3.32 (1.35–8.14) | 0.009 |
Urinary tract source | -1.68 | 0.18 (0.07–0.45) | <0.001 |
Inappropriate empirical therapy | 0.69 | 2.00 (0.95-4.34) | 0.07 |